Astellas Pharma Shares Outstanding 2012-2019 | ALPMY

Astellas Pharma shares outstanding history from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Astellas Pharma shares outstanding for the quarter ending June 30, 2019 were 1.888B, a 11.27% decline year-over-year.
  • Astellas Pharma 2018 shares outstanding were 2.032B, a 4.26% decline from 2017.
  • Astellas Pharma 2017 shares outstanding were 2.123B, a 1.78% decline from 2016.
  • Astellas Pharma 2016 shares outstanding were 2.161B, a 2.31% decline from 2015.
Astellas Pharma Annual Shares Outstanding
(Millions of Shares)
2018 2,032
2017 2,123
2016 2,161
2015 2,212
2014 2,247
2013 2,294
2012 2,340
2011 2,340
2010 2,380
2009 2,520
2008 2,595
2007 2,689
2006 2,819
Astellas Pharma Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 1,888
Q1 2018 2,008
Q1 2017 2,066
Q2 2016 2,160
Q1 2016 2,127
Q4 2016 2,161
Q3 2015 2,170
Q2 2015 2,179
Q1 2015 2,190
Q4 2015 2,212
Q3 2014 2,216
Q2 2014 2,217
Q1 2014 2,223
Q4 2014
Q3 2013
Q2 2013
Q1 2013
Q4 2013
Q3 2012
Q2 2012
Q1 2012
Q4 2012
Q3 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $32.261B $11.834B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $58.852B 35.20
Eisai (ESALY) Japan $20.942B 40.38
Grifols, S.A (GRFS) Spain $15.594B 20.43
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.630B 19.97
Neurocrine Biosciences (NBIX) United States $10.430B 492.39
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.678B 17.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.380B 10.70
Catalent (CTLT) United States $7.634B 31.06
IPSEN SA ADR (IPSEY) France $7.374B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.529B 98.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.932B 17.73
FibroGen (FGEN) United States $4.127B 121.28
United Therapeutics (UTHR) United States $4.059B 0.00
Nektar Therapeutics (NKTR) United States $3.800B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.641B 13.31
Sage Therapeutics (SAGE) United States $3.558B 0.00
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.966B 0.00
ArQule (ARQL) United States $2.439B 0.00
Heron Therapeutics (HRTX) United States $2.304B 0.00
Xencor (XNCR) United States $2.160B 65.65
Portola Pharmaceuticals (PTLA) United States $2.113B 0.00
Zogenix (ZGNX) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.943B 61.95
Pacira Pharmaceuticals (PCRX) United States $1.900B 56.22
Tilray (TLRY) Canada $1.829B 0.00
ChemoCentryx (CCXI) United States $1.812B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.741B 0.00
USANA Health Sciences (USNA) United States $1.621B 17.30
Corcept Therapeutics (CORT) United States $1.551B 18.85
Enanta Pharmaceuticals (ENTA) United States $1.268B 28.95
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.176B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.130B 0.00
Karyopharm Therapeutics (KPTI) United States $1.049B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.041B 7.10
Radius Health (RDUS) United States $1.019B 0.00
Endo (ENDP) Ireland $0.996B 1.83
Aerie Pharmaceuticals (AERI) United States $0.993B 0.00
Flexion Therapeutics (FLXN) United States $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.747B 0.00
Collegium Pharmaceutical (COLL) United States $0.684B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
Dermira (DERM) United States $0.636B 0.00
ImmunoGen (IMGN) United States $0.545B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.530B 0.00
Translate Bio (TBIO) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Organogenesis Holdings (ORGO) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.443B 53.75
Aptorum Group (APM) Hong Kong, SAR China $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.435B 18.74
Harpoon Therapeutics (HARP) United States $0.431B 0.00
Molecular Templates (MTEM) United States $0.412B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.410B 0.00
OptiNose (OPTN) United States $0.394B 0.00
Indivior (INVVY) United States $0.389B 1.41
Rigel Pharmaceuticals (RIGL) United States $0.382B 0.00
Siga Technologies (SIGA) United States $0.379B 8.65
Recro Pharma (REPH) United States $0.378B 0.00
DURECT (DRRX) United States $0.367B 0.00
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.354B 4.12
Corbus Pharmaceuticals Holdings (CRBP) United States $0.318B 0.00
Jounce Therapeutics (JNCE) United States $0.304B 4.06
Rafael Holdings (RFL) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.285B 0.00
KalVista Pharmaceuticals (KALV) United States $0.276B 0.00
Concordia (CXRXF) Canada $0.269B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.267B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
GlycoMimetics (GLYC) United States $0.242B 0.00
Xeris Pharmaceuticals (XERS) United States $0.241B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.191B 32.93
AcelRx Pharmaceuticals (ACRX) United States $0.190B 0.00
Concert Pharmaceuticals (CNCE) United States $0.188B 0.00
Taiwan Liposome (TLC) Taiwan $0.178B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.170B 0.00
IMV INC (IMV) Canada $0.157B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.146B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
CannTrust Holdings (CTST) Canada $0.116B 0.00
CV Sciences (CVSI) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.088B 0.00
Capnia (SLNO) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 23.64
Otonomy (OTIC) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Forward Pharma (FWP) Denmark $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Novan (NOVN) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.057B 14.29
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.053B 0.00
Mast Therapeutics (SVRA) United States $0.050B 0.00
AgeX Therapeutics (AGE) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
IsoRay (ISR) United States $0.042B 0.00
Opexa Therapeutics (ACER) United States $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Shineco (TYHT) China $0.028B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Cardiome Pharma (CORV) Canada $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00